Kurt M. Eichler, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 76,923 shares at $13.00 ($1000K) on 2017-06-27, disclosed to the SEC on 2017-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SBPH | BUY | 2016-11-10 | $61K | — | Filing → |
| SBPH | BUY | 2016-09-20 | $25K | — | Filing → |
| SBPH | BUY | 2016-09-15 | $6K | — | Filing → |